Integrative molecular profiling identifies two molecularly and clinically distinct subtypes of blastic plasmacytoid dendritic cell neoplasm

Blood Cancer J. 2022 Jul 4;12(7):101. doi: 10.1038/s41408-022-00699-1.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Dendritic Cells
  • Humans
  • Myeloproliferative Disorders*
  • Skin Neoplasms*